ATI RN
ATI Pharmacology 2023 III Questions
Extract:
Question 1 of 5
A nurse is caring for a client who is receiving magnesium sulfate IV bolus for preeclampsia. The client's respiratory rate is 6/min and they have absent deep tendon reflexes. Which of the following medications should the nurse anticipate the provider to prescribe?
Correct Answer: B
Rationale: The correct answer is B: Calcium gluconate. In this scenario, the client is likely experiencing magnesium toxicity, characterized by respiratory depression and absent deep tendon reflexes. Calcium gluconate is the antidote for magnesium sulfate toxicity as it antagonizes the effects of magnesium on the neuromuscular system, restoring neuromuscular excitability and potentially preventing cardiac arrest. Methylergonovine (
A) is used to prevent or control postpartum hemorrhage, not for magnesium toxicity. Naloxone (
C) is used to reverse opioid overdose, not magnesium toxicity. Dexamethasone (
D) is a corticosteroid used for anti-inflammatory and immunosuppressant effects, not for magnesium toxicity.
Question 2 of 5
A nurse is caring for a client who has a gonococcal infection and has been prescribed an 1M injection of ceftriaxone. The client refuses the medication because they are afraid of needles. Which of the following responses should the nurse make?
Correct Answer: D
Rationale: The correct response is D: "I will discuss other treatment options with your provider." The nurse should respect the client's autonomy and explore alternative treatment options that the client may be more comfortable with. This response demonstrates patient-centered care and promotes shared decision-making.
Choices A and B are coercive and may damage the therapeutic relationship.
Choice C minimizes the client's fear and may be perceived as dismissive.
Question 3 of 5
A nurse is preparing to administer heparin subcutaneously to a client. Which of the following actions should the nurse plan to take to minimize bleeding following the injection?
Correct Answer: B
Rationale: The correct answer is B: Grasp skin between thumb and forefinger throughout the injection. This technique helps to create tension in the skin, making it easier for the needle to penetrate the subcutaneous tissue and reducing the risk of bleeding. Massaging the site (choice
A) can actually increase the risk of bleeding by disrupting the clotting process. The Z-track method (choice
C) is used for intramuscular injections, not subcutaneous. Aspirating the syringe (choice
D) is not necessary for subcutaneous injections as there are no large blood vessels in the subcutaneous tissue.
Therefore, grasping the skin between thumb and forefinger is the correct technique to minimize bleeding following a subcutaneous injection.
Question 4 of 5
A nurse is caring for a client in the post-anesthesia unit who is experiencing malignant hyperthermia. Which of the following prescriptions should the nurse anticipate administering?
Correct Answer: D
Rationale: The correct answer is D: Dantrolene. Malignant hyperthermia is a potentially life-threatening condition triggered by certain anesthetics. Dantrolene is the specific antidote for malignant hyperthermia as it works to inhibit calcium release from the sarcoplasmic reticulum, preventing muscle contraction and reducing body temperature. Verapamil (
A) is a calcium channel blocker and not indicated for malignant hyperthermia. Naloxone (
B) is an opioid antagonist used for opioid overdose, not for malignant hyperthermia. Cefazolin (
C) is an antibiotic used for infection, not for malignant hyperthermia.
Therefore, the correct choice is Dantrolene (
D) for treating malignant hyperthermia.
Question 5 of 5
A nurse is caring for a client who has received propofol during a colonoscopy. The nurse should monitor for which of the following as an adverse effect of the medication?
Correct Answer: B
Rationale: The correct answer is B: Decrease in respiratory rate. Propofol is a sedative-hypnotic medication that can cause respiratory depression as a side effect. This occurs due to its central nervous system depressant effects, leading to a decrease in the drive to breathe. Monitoring for a decrease in respiratory rate is crucial to prevent respiratory compromise or failure. The other options are incorrect because propofol does not typically cause an increase in heart rate (
A), bowel function (
C), or body temperature (
D) as its primary adverse effects.